The NM23 gene and its expression in oral squamous cell carcinoma.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Oncology Report

• Publication date

  1999-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OR.6.4.747PMID 10373649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of nucleoside diphosphate kinase nm23-H2 with human telomeres.

  1998cited by this paper
• nm23‐H1 expression in nasopharyngeal carcinoma: correlation with clinical outcome

  1998cited by this paper
• Identification of Novel mRNA Transcripts of the nm23-M1 Gene that Are Modulated during Mouse Embryo Development and Are Differently Expressed in Adult Murine Tissues

  1998cited by this paper
• Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.

  1998cited by this paper
• Immunohistochemical study on the nm23 gene produce (NDP kinase) in oral squamous cell carcinoma.

  1997cited by this paper
• The prediction of lymph node metastases in colorectal cancer by expression of the nucleoside diphosphate kinase/nm23-H1 and histopathological variables.

  1997cited by this paper
• Expression of nm23 protein in pulmonary adenocarcinomas: inverse 1orrelation to tumor progression.

  1997cited by this paper
• The association between nm23 gene expression and survival in patients with sarcomas.

  1997cited by this paper
• Squamous cell lung carcinomas: the role of nm23-H1 gene

  1997cited by this paper
• Immunohistochemical analysis of nucleoside diphosphate kinases in oral squamous cell carcinomas.

  1997cited by this paper
• Loss of heterozygosity of the nm23-H1 gene in human renal cell carcinomas.

  1997cited by this paper
• Automated and quantitative immunocytochemical assays of Nm23/NDPK protein in breast carcinomas

  1997cited by this paper
• NM23 gene expression in human breast carcinomas: Loss of correlation with cell proliferation in the advanced phase of tumor progression

  1997cited by this paper
• Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma.

  1996cited by this paper
• Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.

  1996cited by this paper
• Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.

  1996cited by this paper
• Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion.

  1996cited by this paper
• nm23‐H1 protein immunoreactivity in laryngeal carcinoma

  1996cited by this paper
• The potential roles of nm23 in cancer metastasis and cellular differentiation.

  1995cited by this paper
• NM23 gene expression correlates with cell growth rate and S‐phase

  1995cited by this paper
• Colon carcinoma cells with inactive nm23 show increased motility and response to motility factors.

  1995cited by this paper
• Overexpression of nm23-H1 and nm23-H2 genes in colorectal carcinomas and loss of nm23-H1 expression in advanced tumour stages.

  1995cited by this paper
• Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.

  1994cited by this paper
• Expression of nm23 H‐1 RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis

  1994cited by this paper
• Expression of human nm23‐H1 and nm23‐H2 proteins in hepatocellular carcinoma

  1994cited by this paper
• Human c-myc transcription factor PuF identified as nm23-H2 nucleoside diphosphate kinase, a candidate suppressor of tumor metastasis.

  1993cited by this paper
• Reduced expression of nm23‐H1, but not of nm23‐H2, is concordant with the frequency of lymph‐node metastasis of human breast cancer

  1993cited by this paper
• Reduced Expression of nm23 Is Associated with Metastasis of Human Gastric Carcinomas

  1993cited by this paper
• Expression of nm23‐Hl and nm23‐H2 Proteins in Prostate Carcinoma

  1993cited by this paper
• A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential.

  1993cited by this paper
• Expression of the nm23-2/NDP kinase alpha gene in rat mammary and oral carcinoma cells of varying metastatic potential.

  1993cited by this paper
• Inhibition of cell motility after nm23 transfection of human and murine tumor cells.

  1993cited by this paper
• Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.

  1992cited by this paper
• Embryonic expression of nm23 during mouse organogenesis.

  1992cited by this paper
• Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.

  1991cited by this paper
• Positive relationship between expression of anti-metastatic factor (nm23 gene product or nucleoside diphosphate kinase) and good prognosis in human breast cancer.

  1991cited by this paper
• Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis.

  1991cited by this paper
• Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.

  1989cited by this paper
• Reduced Nm23/Awd protein in tumour metastasis and aberrant Drosophila development

  1989cited by this paper
• Evidence for a novel gene associated with low tumor metastatic potential.

  1988cited by this paper
• Altered expression of NM23, a gene associated with low tumor metastatic potential, during adenovirus 2 Ela inhibition of experimental metastasis.

  1988cited by this paper

• Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC

  2024cites this paper
• NDPKA is not just a metastasis suppressor – be aware of its metastasis-promoting role in neuroblastoma

  2018cites this paper
• The telomere proteins in tumorigenesis and clinical outcomes of oral squamous cell carcinoma.

  2016cites this paper
• CORRELATION BETWEEN PROTEIN nm 23 AND CATHEPSIN D WITH CLINICAL AND PATHOLOGICAL FEATURES OF ORAL SQUAMOUS CELL CARCINOMA Č

  2016cites this paper
• Metastases suppressor NME2 associates with telomere ends and telomerase and reduces telomerase activity within cells

  2011cites this paper
• Identification of Tetranectin as a Potential Biomarker for Metastatic Oral Cancer

  2010cites this paper
• Basic Science Review: Nitric Oxide—Releasing Prosthetic Materials

  2009cites this paper
• Nm23‐H1 promotes adhesion of CAL 27 cells in vitro

  2009cites this paper
• Nm23‐H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma

  2008cites this paper
• NM23 as a prognostic biomarker in ovarian serous carcinoma

  2008cites this paper
• Gene expression profiling of Nm23-H2 overexpressing CAL 27 cells using DNA microarray.

  2008cites this paper
• with radical radiotherapy head and neck squamous-cell carcinoma treated expressions in predicting outcome of patients with Value of ezrin, maspin and nm23-H1 protein

  2008cites this paper
• A cell proteomic approach for the detection of secretable biomarkers of invasiveness in oral squamous cell carcinoma.

  2007cites this paper
• Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy

  2006cites this paper
• Downstream targets of Nm23‐H1: Gene expression profiling of CAL 27 cells using DNA microarray

  2006cites this paper
• BASIC SCIENCE REVIEW

  2005cites this paper
• Molecular mediators of metastasis in head and neck squamous cell carcinoma

  2005cites this paper
• Invasion and Metastasis of Oral Cancer Cells Require Methylation of E-Cadherin and/or Degradation of Membranous β-Catenin

  2004cites this paper
• Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma

  2004cites this paper
• Expression of Mesenchyme-Specific Gene HMGA2 in Squamous Cell Carcinomas of the Oral Cavity

  2004cites this paper
• Oncogenes and Tumor Suppressor Genes in Oral or Head and Neck Squamous Cell Carcinoma

  2003cites this paper
• Expression of the p53 and nm23 Genes in Cholesteatoma

  2002cites this paper
• Genetic aberrations in oral or head and neck squamous cell carcinoma 3: clinico-pathological applications.

  2000cites this paper
• Nucleoside diphosphate kinase beta (Nm23-R1/NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma.

  2000cites this paper
• Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations.

  2000cites this paper
• Nm23/Nucleoside Diphosphate Kinase in Human Cancers

  2000cites this paper
• Correlation between nm23-H1 overexpression and clinicopathological variables in human anal canal carcinoma.

  1999cites this paper